Dr. Sparks’ Research Group works to better illuminate road lines

Increasing the visibility of roadway markings is an important task for engineers. The most popular approach for making roadway striping more visible has been to add glass beads to the surface of the roadway paint in order to cause some of the light from headlights to retro-reflect back to the car. However, when paint with retroreflective beads is submerged with water the index of refraction of water prevents the light from retro-reflecting and the roadway markings become nearly impossible to observe. The easiest workaround for this problem is to add retroreflective tabs to roads, but in our snowy climate the snowplows would rip tabs off the road leaving Utah with no great solutions.

Phosphorescent roadway paint featuring high-performance Eu:SrAl2O4 phosphors with the patent-pending protective polymer coating innovation from the Sparks Research Group.

The Taylor Sparks Research Group has set out to develop a potential alternative solution based on “glow in the dark” luminescent phosphors. Glow in the dark roadways have been piloted before in the Netherlands and failed spectacularly after only a few weeks due to rainwater causing the rare-earth elements to leach out of the ceramic phosphor in the paint. The innovation was led by group member Jason Nance (M.S., ’19) who performed his Master’s degree in Materials Science and Engineering (MSE) while working as the state chemist for the Utah Department of Transportation (UDOT).

Nance and Dr. Taylor Sparks developed a custom polymer coating for the ceramic phosphors that prevents the rare-earth ion from leaching out when submerged in water for prolonged periods. A provisional patent has been filed and a full patent application is under review. Sparks and Nance hope to commercialize this paint through their startup, JCS Labs, and will be conducting feasibility tests on public roads with UDOT this summer.

Dr. Sparks and Nance were recently interviewed by Fox13 News in Salt Lake City about their research and development, watch the interview here.

Metallurgy Ph.D. Now Makes Medical Radioisotopes

During his Ph.D. studies in the Department of Metallurgical Engineering at the University of Utah, Dr. Milan Stika studied molten salt electrochemistry under Prof. Michael Simpson. They worked on methods for measuring concentrations of actinides in molten salts used for applications such as nuclear reactors and nuclear fuel reprocessing. After a brief stint working for Flibe Energy on development of molten salt fueled nuclear reactors, Milan now works at Niowave, Inc., a company that produces radioisotopes used for medical diagnostics and cancer treatment. The company has a great team of accelerator physicists, nuclear engineers, and radiochemists supporting its mission. As a radiochemist, Milan works on projects that deal with separation of individual radioactive elements.

Niowave irradiates uranium targets to induce fission which creates a variety of useful fission products. The target is then dissolved so that fission products like molybdenum-99 can be harvested. Uranium is first pulled away from the rest of the elements using solvent extraction. It is then recycled into a new target. The elements useful for medical applications are then separated from each other using ion exchange resins and other methods.

Niowave also irradiates radium targets to produce actinium-225, a useful medical isotope along with other alpha emitters for targeted alpha therapy. Actinium is separated from radium and other products of the radium decay chain. Niowave is currently the only US private company producing actinium-225.

According to Milan, “the Department of Metallurgical Engineering was instrumental in helping me prepare for this exciting job in the nuclear sector by offering relevant coursework, networking opportunities, and advisor guidance.”